1. Italy Stocks

  2. •

    Retail trade

  3. •

    Specialty stores
Farmacosmo S.P.A.

Farmacosmo S.P.A.

MMIL:COSMO
0.44
EUR
+0.02
(+4.52%)
36.48MMarket Cap
Mar 03Next Earn
Farmacosmo S.P.A.
MIL:COSMO
(Euronext Milan)

Recent

price

0.44

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2022
2023
2024
2025
TTM
EUR
0.73
1.32
1.75
1.84
1.63
1.43
- -
Revenue per Share
- -
0.01
-0.04
-0.08
-0.08
-0.11
- -
Basic EPS, GAAP
- -
0.04
- -
-0.18
-0.09
-0.06
- -
Free Cash Flow per Basic Share
- -
0.01
- -
- -
- -
- -
- -
Dividend per Share
0.01
0.02
0.46
0.33
0.27
0.14
0.27
Book Value per Share
-0.01
-0.01
0.03
-0.07
-0.05
-0.16
-0.05
Tangible Book Value per Share
33
33
38
39
39
39
39
Basic Weighted Avg Shares
24
44
66
72
63
56
- -
Sales/Revenue/Turnover
1.55
1.92
-2.29
-4.24
-3.25
-9.83
- -
Operating Margin (%)
- -
- -
2
3
3
3
- -
Depreciation Expense
- -
- -
-1
-3
-3
-4
- -
Net Income, GAAP
34.95
28.74
- -
- -
- -
- -
- -
Effective Tax Rate (%)
0.55
0.85
-2.03
-4.52
-4.69
-7.96
- -
Profit Margin (%)
- -
- -
2
- -
-1
-4
-1
Working Capital
- -
- -
- -
- -
1
1
1
LT Debt
- -
1
19
15
11
5
11
Total Equity
- -
37.49
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
71.73
- -
- -
- -
- -
- -
Return on Capital (%)
- -
79.87
-14.9
-21.32
-25.29
-55.26
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
ST Debt
- -
6
7
LT Borrowings
- -
- -
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
39
39
39
Market Capitalization
27
31
36

Working Capital

EUR

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
Total Current Assets
20
20
18
Cash, Cash Equivalents & STI
5
5
3
Accounts Receivable, Net
5
4
4
Inventories
7
8
9
Total Current Liabilities
20
20
19
Payables & Accruals
- -
- -
- -
ST Debt
- -
6
7
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
656.83%
-51.16%
Free Cash Flow
- -
- -
-35.6%
Net Income, GAAP
- -
-19.46%
49.11%
Sales/Revenue/Turnover
- -
23.16%
-12.23%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
72
2024
- -
- -
63
2025
- -
- -
56

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.08
2024
- -
- -
-0.08
2025
- -
- -
-0.11

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Similar Companies
Walmart Inc. (NASDAQ:WMT)
Costco Wholesale Corporation (NASDAQ:COST)
Target Corporation (NYSE:TGT)
Kalyan Jewellers India Ltd. (NSE:KALYANKJIL)
Carvana Co. (NYSE:CVNA)
Copart, Inc. (NASDAQ:CPRT)
Business
Farmacosmo S.p.A. is an Italy-based digital retailer and health-tech company engaged in the online distribution of pharmaceuticals, personal wellness, beauty, and pet care products, alongside the provision of integrated digital healthcare solutions. Founded in 2014 and headquartered in Naples, Italy, the company operates proprietary B2C e-commerce platforms and B2B channels primarily serving the Italian domestic market and expanding into select European territories. Farmacosmo organizes its commercial offerings across specialized business segments, including Health & Pharma, Beauty & Fragrances, Personal Care, Pet Care, Mother & Child, and Digital Health. Its comprehensive product and service portfolio includes over-the-counter (OTC) pharmaceuticals and non-prescription medicines; dietary supplements, vitamins, and nutraceuticals; dermocosmetics, skincare treatments, hair care solutions, fragrances, and luxury makeup; personal hygiene, dental care, and sanitization items; medical devices, diagnostic testing kits, orthopedic supports, and health monitoring equipment; infant nutrition, baby care essentials, and maternity products; veterinary medicines, specialty pet food, and pet hygiene accessories; optical goods, contact lenses, and eye care solutions; and digital telemedicine services, including remote specialist consultations and telecardiology diagnostics. In recent corporate developments, Farmacosmo completed its listing on the Euronext Growth Milan exchange to accelerate external expansion and technological innovation. The company has executed a targeted merger and acquisition campaign, acquiring majority stakes in online perfumery platform ProfumeriaWeb to strengthen its selective beauty and cosmetics vertical, e-pharmacy platform Phàrmasi to consolidate its core online pharmaceutical market share, and Contacta to expand into the optical and vision-care market. Additionally, Farmacosmo acquired Telemedico to integrate remote diagnostic and teleconsultation services into its digital platform, entered the eco-sustainable pet care segment through the acquisition of Bau Cosmesi, and formed strategic alliances with specialized logistics and pharmaceutical partners to enhance automated order fulfillment and rapid delivery operations.